Imugene Limited (IUGNF)
OTCMKTS · Delayed Price · Currency is USD
0.1673
0.00 (0.00%)
Mar 17, 2026, 4:00 PM EST
Imugene Income Statement
Financials in millions AUD. Fiscal year is July - June.
Millions AUD. Fiscal year is Jul - Jun.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 |
Other Revenue | 3.94 | 4.4 | 4.97 | 11.78 | 12.97 | 7.23 |
Revenue | 3.94 | 4.4 | 4.97 | 11.78 | 12.97 | 7.23 |
Revenue Growth (YoY) | - | -11.53% | -57.80% | -9.19% | 79.35% | 74.94% |
Gross Profit | 3.94 | 4.4 | 4.97 | 11.78 | 12.97 | 7.23 |
Selling, General & Admin | 17.23 | 27.77 | 59.91 | 20.43 | 14.06 | 10.31 |
Research & Development | 45.88 | 46.69 | 86.89 | 30.86 | 36.61 | 15.36 |
Operating Expenses | 63.11 | 74.46 | 146.79 | 51.29 | 50.67 | 25.67 |
Operating Income | -59.17 | -70.06 | -141.82 | -39.52 | -37.7 | -18.43 |
Interest Expense | -0.12 | -0.16 | -0.48 | -0.03 | -0.01 | -0.01 |
Interest & Investment Income | 0.91 | 2.08 | 4.52 | 1.88 | 0.19 | 0.13 |
Currency Exchange Gain (Loss) | 0.06 | -0.67 | -0.63 | -0.25 | -0.13 | -0.08 |
Other Non Operating Income (Expenses) | - | - | - | - | -0.11 | -0.11 |
EBT Excluding Unusual Items | -58.31 | -68.81 | -138.42 | -37.91 | -37.76 | -18.51 |
Gain (Loss) on Sale of Assets | -0.19 | -0.21 | -11.26 | -0 | -0.1 | - |
Other Unusual Items | - | - | - | - | - | 0.05 |
Pretax Income | -58.5 | -69.02 | -149.68 | -37.91 | -37.87 | -18.46 |
Net Income | -58.5 | -69.02 | -149.68 | -37.91 | -37.87 | -18.46 |
Net Income to Common | -58.5 | -69.02 | -149.68 | -37.91 | -37.87 | -18.46 |
Shares Outstanding (Basic) | 256 | 219 | 208 | 185 | 166 | 137 |
Shares Outstanding (Diluted) | 256 | 219 | 208 | 185 | 166 | 137 |
Shares Change (YoY) | 18.24% | 4.90% | 12.96% | 11.33% | 20.88% | 14.45% |
EPS (Basic) | -0.23 | -0.32 | -0.72 | -0.21 | -0.23 | -0.13 |
EPS (Diluted) | -0.23 | -0.32 | -0.72 | -0.21 | -0.23 | -0.13 |
Free Cash Flow | -59.68 | -83.12 | -108.8 | -31.47 | -31.11 | -13.42 |
Free Cash Flow Per Share | -0.23 | -0.38 | -0.52 | -0.17 | -0.19 | -0.10 |
Gross Margin | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% |
Operating Margin | -1500.10% | -1593.52% | -2853.55% | -335.51% | -290.70% | -254.92% |
Profit Margin | -1483.31% | -1569.81% | -3011.66% | -321.92% | -291.98% | -255.21% |
Free Cash Flow Margin | -1513.04% | -1890.42% | -2189.12% | -267.21% | -239.83% | -185.53% |
EBITDA | -46.92 | -67.42 | -137.45 | -37.31 | -35.45 | -16.55 |
EBITDA Margin | - | - | - | - | -273.30% | -228.81% |
D&A For EBITDA | 12.25 | 2.64 | 4.38 | 2.2 | 2.26 | 1.89 |
EBIT | -59.17 | -70.06 | -141.82 | -39.52 | -37.7 | -18.43 |
EBIT Margin | - | - | - | - | -290.70% | -254.92% |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.